BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15308198)

  • 1. Biodistribution studies of boronophenylalanine-fructose in melanoma and brain tumor patients in Argentina.
    Liberman SJ; Dagrosa A; Jiménez Rebagliati RA; Bonomi MR; Roth BM; Turjanski L; Castiglia SI; González SJ; Menéndez PR; Cabrini R; Roberti MJ; Batistoni DA
    Appl Radiat Isot; 2004 Nov; 61(5):1095-100. PubMed ID: 15308198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First BNCT treatment of a skin melanoma in Argentina: dosimetric analysis and clinical outcome.
    González SJ; Bonomi MR; Santa Cruz GA; Blaumann HR; Calzetta Larrieu OA; Menéndez P; Jiménez Rebagliati R; Longhino J; Feld DB; Dagrosa MA; Argerich C; Castiglia SG; Batistoni DA; Liberman SJ; Roth BM
    Appl Radiat Isot; 2004 Nov; 61(5):1101-5. PubMed ID: 15308199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
    Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
    Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
    H-Stenstam B
    Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam.
    Kiger WS; Lu XQ; Harling OK; Riley KJ; Binns PJ; Kaplan J; Patel H; Zamenhof RG; Shibata Y; Kaplan ID; Busse PM; Palmer MR
    Appl Radiat Isot; 2004 Nov; 61(5):1075-81. PubMed ID: 15308195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo (19)F MRI and (19)F MRS of (19)F-labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT).
    Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Campanella R; Migneco LM; Pastore FS; Maraviglia B
    Phys Med Biol; 2008 Dec; 53(23):6979-89. PubMed ID: 19001698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent.
    Matalka KZ; Bailey MQ; Barth RF; Staubus AE; Soloway AH; Moeschberger ML; Coderre JA; Rofstad EK
    Cancer Res; 1993 Jul; 53(14):3308-13. PubMed ID: 8324742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
    Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
    Morris GM; Micca PL; Coderre JA
    Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.
    Coderre JA; Chanana AD; Joel DD; Elowitz EH; Micca PL; Nawrocky MM; Chadha M; Gebbers JO; Shady M; Peress NS; Slatkin DN
    Radiat Res; 1998 Feb; 149(2):163-70. PubMed ID: 9457896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1H MRS studies in the Finnish boron neutron capture therapy project: detection of 10B-carrier, L-p-boronophenylalanine-fructose.
    Timonen M; Kankaanranta L; Lundbom N; Collan J; Kangasmäki A; Kortesniemi M; Häkkinen AM; Lönngren A; Karjalainen S; Rasilainen M; Leinonen J; Huitti T; Jääskeläinen J; Kouri M; Savolainen S; Heikkinen S
    Eur J Radiol; 2005 Nov; 56(2):154-9. PubMed ID: 16233888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study.
    Kankaanranta L; Seppälä T; Koivunoro H; Välimäki P; Beule A; Collan J; Kortesniemi M; Uusi-Simola J; Kotiluoto P; Auterinen I; Serèn T; Paetau A; Saarilahti K; Savolainen S; Joensuu H
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):369-76. PubMed ID: 21236605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
    Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
    Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Models for estimation of the (10)B concentration after BPA-fructose complex infusion in patients during epithermal neutron irradiation in BNCT.
    Ryynänen PM; Kortesniemi M; Coderre JA; Diaz AZ; Hiismäki P; Savolainen SE
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1145-54. PubMed ID: 11072174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
    Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
    Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic model for the concentration of 10B in blood after boronophenylalanine-fructose administration in humans.
    Kiger WS; Palmer MR; Riley KJ; Zamenhof RG; Busse PM
    Radiat Res; 2001 Apr; 155(4):611-8. PubMed ID: 11260663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boron biodistribution study in colorectal liver metastases patients in Argentina.
    Cardoso J; Nievas S; Pereira M; Schwint A; Trivillin V; Pozzi E; Heber E; Monti Hughes A; Sanchez P; Bumaschny E; Itoiz M; Liberman S
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S76-9. PubMed ID: 19375931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boron biodistribution in beagles after intravenous infusion of 4-dihydroxyborylphenylalanine-fructose complex.
    Kulvik ME; Vähätalo JK; Benczik J; Snellman M; Laakso J; Hermans R; Järviluoma E; Rasilainen M; Färkkilä M; Kallio ME
    Appl Radiat Isot; 2004 Nov; 61(5):975-9. PubMed ID: 15308178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.